Award
National Institute on Aging 1R43AG097403-01
Democratizing Early Detection and Longitudinal Monitoring of Alzheimer's Disease: An Ultra-Sensitive Blood-Based Assay
Recipient
Not specified
Award Amount
$506,061.00
Ceiling
$506,061.00
Awarded
September 15, 2025
Identifier
1R43AG097403-01
Award to develop an ultra-sensitive blood-based assay for early detection and monitoring of Alzheimer's disease using the SiMoLiSA platform, including biomarker panel establishment and clinical validation.
Description
This project aims to develop the SiMoLiSA platform for early detection of Alzheimer's disease, focusing on creating an affordable, sensitive, and scalable blood-based assay. The project includes establishing a 7-biomarker panel and validating it with clinical samples in a CLIA-certified lab.